Refine by
Diagnostics Enters Into Development Suppliers & Manufacturers
170 companies found
based inBoston, MASSACHUSETTS (USA)
Sherlock Biosciences is dedicated to providing global access to the simplest and most accurate tests that empower individuals to control their own healthcare. Through its Engineering Biology platforms, the company is developing applications of ...
based inKAARINA, FINLAND
Labmaster Oy Ltd. is a company engaged in the design, development, and manufacturing of various products, ensuring they meet specified criteria through proper storage, usage, and transportation guidelines. They emphasize adherence to instructions ...
based inEGYPT
UltraCare Co., Ltd., established in 2016, is a dedicated enterprise focused on research and manufacturing of clinical in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio covering key platforms such as biochemistry, ...
based inSariyer Istanbul, TURKEY
ARGENIT aims to help physicians make the best diagnosis in the fastest way with its advanced biomedical imaging systems and develops new diagnostic solutions tailored to laboratory needs that deliver high-quality clinical value and user experience ...
based inMissoula, MONTANA (USA)
FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...
based inBellevue, WASHINGTON (USA)
We set out to completely redesign the arrhythmia monitor to elevate signal detection, comfort, and ease of use. Using feedback from patients, clinicians and physicians, we addressed the long-standing complaint in cardiac arrhythmia monitoring that ...
based inSuwon-si, SOUTH KOREA
SD BIOSENSOR is a professional in-vitro diagnostics company with aims of contributing to higher life quality by diagnosing illnesses accurately and quickly. SD BIOSENSOR is researching and developing quick diagnostics, immunodiagnostics, molecular ...
based inOklahoma City, OKLAHOMA (USA)
By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
based inPforzheim, GERMANY
Novotec Medical was founded 2001 and is based in Pforzheim, southern Germany. It is a TÜV-certified manufacturer of Galileo Training devices, Galileo Therapy devices and of Leonardo Mechanography motion analysis systems.To ensure highest quality all ...
based inNew York, NEW YORK (USA)
Acuamark Diagnostics develops technology which allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced team of scientific and business ...
based inNorth Kingstown, RHODE ISLAND (USA)
A Leader in Clinical Diagnostics and Information. Dominion Diagnostics provides clinical drug monitoring solutions, actionable clinical information and innovative support services to a variety of medical specialties. At Dominion Diagnostics, we’re ...
based inBroomfield, COLORADO (USA)
Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and ...
Your next pathology-based CDx starts here. With the complexity of therapies increasing, the need for a robust companion diagnostic (CDx) has never been higher. Advances in tissue analysis technologies now require a more quantitative, accurate, and ...
based inSan Jose, CALIFORNIA (USA)
Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application ...
based inBrentwood, TENNESSEE (USA)
Cairn Diagnostics is a specialized, innovative technology company focused on pioneering, manufacturing, validating and obtaining FDA-approvals for novel breath tests intended for routine use in diagnostic medicine. Cairn develops orally administered ...
based inSan Diego, CALIFORNIA (USA)
Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved ...
based inIstanbul, TURKEY
Archem Diagnostics; Our main focus is IVD reagents manufacturing and marketing. Having started its operations in 1998, Archem Diagnostics is one of the well-established biochemistry and hematology reagents manufacturer companies in Turkey. Our ...
based inDeeside, UNITED KINGDOM
Biofortuna is a specialist contract development and manufacturing organisation providing Genomic services, custom development and manufacturing support. Operating from state-of-the art, humidity-controlled premises, and benefiting from ISO 17025 ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
based inWest Lafayette, INDIANA (USA)
Tymora Analytical Operations provides diagnostic development and exosome proteomics contract services and products for improved cancer research. Tymora’s primary goal is to enable the shift from tissue to liquid biopsy. Our new technologies allow ...
